Current Affairs - Technology - Discussion

AIIMS Delhi played a pioneering role by conducting India’s first dedicated clinical trial of an advanced brain stent under the GRASSROOT trial. The trial evaluated the safety and efficacy of the indigenously developed Supernova stent for treating severe strokes, particularly large vessel occlusion cases. Conducted across multiple medical centres, the study produced high-quality clinical evidence that led to CDSCO approval based solely on domestic data. This achievement strengthened India’s medical research ecosystem, reduced reliance on foreign trials, and supported national initiatives such as Make in India and Atmanirbhar Bharat in the medical devices sector.